FDA issued a Warning Letter to Megafine Pharma Limited on 5/19/2016 for a previous inspection.
483 Megafine Pharma (P) May 2018

483 Megafine Pharma (P) May 2018

Arsen Karapetyan FDA, Pratik Upadhyay FDA$119.00 - Available Now

FDA investigators audited the Megafine Pharma (P) - Lakhamapur, India facility and issued inspectional observations (via FDA 483) on 12 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 May 2018
  • Location: Lakhamapur, India
  • FEI: 3005694111
Add To Cart